Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.3K Buy
2,194
+1,054
+92% +$6.99K ﹤0.01% 3060
2026
Q1
$5.91K Sell
1,140
-820
-42% -$5.13K ﹤0.01% 3303
2025
Q4
$14.3K Sell
1,960
-405
-17% -$3.92K ﹤0.01% 2798
2025
Q3
$23.6K Sell
2,365
-220
-9% -$2.44K ﹤0.01% 2435
2025
Q2
$23.4K Buy
2,585
+151
+6% +$985 ﹤0.01% 2374
2025
Q1
$15.6K Buy
2,434
+1,499
+160% +$13.3K ﹤0.01% 2525
2024
Q4
$8.89K Buy
935
+848
+975% +$7.44K ﹤0.01% 2672
2024
Q3
$710 Sell
87
-2,619
-97% -$27.2K ﹤0.01% 3335
2024
Q2
$36.6K Buy
2,706
+2,682
+11,175% +$22.4K 0.01% 1415
2024
Q1
$168 Sell
24
-647
-96% -$5.62K ﹤0.01% 3243
2023
Q4
$5.46K Buy
+671
New +$6.59K ﹤0.01% 2201

Other funds holding ENVX

GAMMA Investing's ENVX Position: Q2 2026 in Review

GAMMA Investing increased its Enovix (ENVX) stake by 92% in Q2 2026, buying an estimated $6.99K and bringing the position to 2,194 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3060.

GAMMA Investing first reported a position in ENVX in Q4 2023 and has held it in 11 quarters since. The position peaked at $36.6K in Q2 2024. 298 funds tracked by Wall St. Rank hold ENVX as of Q2 2026.

  • GAMMA Investing held 2,194 shares of Enovix worth $13.3K as of Q2 2026.
  • GAMMA Investing bought 1,054 Enovix shares in Q2 2026, an estimated $6.99K.
  • Enovix made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3060 holding.
  • GAMMA Investing first reported a position in Enovix in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Enovix position peaked at $36.6K in Q2 2024.
  • 298 funds tracked by Wall St. Rank held Enovix as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.